scholarly journals Cardiopulmonary assessment of patients diagnosed with Gaucher’s disease type I

Author(s):  
Marija Bjelobrk ◽  
Milan Lakocevic ◽  
Svetozar Damjanovic ◽  
Milan Petakov ◽  
Milan Petrovic ◽  
...  
2000 ◽  
Vol 10 (10) ◽  
pp. 1660-1663 ◽  
Author(s):  
L. W. Poll ◽  
J.-A. Koch ◽  
S. vom Dahl ◽  
E. Loxtermann ◽  
M. Sarbia ◽  
...  

2018 ◽  
Vol 63 (1) ◽  
pp. 33
Author(s):  
Ajantha Keshavaraj ◽  
Lija Gajalakshan

1994 ◽  
Vol 425 (5) ◽  
Author(s):  
Y. Morimura ◽  
H. Hojo ◽  
M. Abe ◽  
H. Wakasa

PLoS ONE ◽  
2021 ◽  
Vol 16 (12) ◽  
pp. e0260241
Author(s):  
Olivia Esteban ◽  
Miguel Angel Torralba ◽  
Susana Olivera ◽  
Mireya Martinez ◽  
Paula Montes ◽  
...  

Background Gaucher’s disease is associated with a high variety of structural and functional abnormalities in the eye, which do not always affect visual acuity. The purpose of this study was to analyse ocular features in Spanish patients with Gaucher’s disease type I, and to investigate their possible correlation with phenotypic and burden parameters of this entity. Methods This cross-sectional observational study compared parameters belonging to 18 eyes from 9 Spanish patients with Gaucher’s disease Type I with 80 eyes from 40 healthy controls. Complete ophthalmological examination included choroidal and retinal thickness maps with swept source optical coherence tomography. Systemic analysis included genotype, plasmatic biomarkers, [ferritin, chemokine ligand 18 (CCL18) and chitotriosidase (ChT)] and severity scoring systems results [“Gaucher Disease Severity Score Index Type I" (GauSSI-I) and “Gaucher disease severity scoring system” (GD-DS3)]. Results Nine subjects (18 eyes) were cases (female: 55.5%, mean age 45 years; male: 44.5%, mean age 36 years) and 40 subjects (80 eyes) were controls (female: 49%, mean age 50 years; male: 51%, mean age 55 years). There were no statistically significant differences when comparing ocular parameters (visual acuity; axial length, refractive errors, corneal parameters, lens, retinal and choroidal thickness) between case and control subjects (p>0.05). A statistically significant moderate correlation was observed between lower retinal thickness and choroidal quadrants thickness and greater disease severity scores. A lower central retinal thickness also correlates with higher biological plasmatic levels, and has a statistically significant association with the most affected patient with genotype N370S/Del 55pb. Conversely, higher pachymetry involves a more severe plasmatic concentration of biomarkers. Conclusions Our results suggest that pachymetry, and retinal and choroidal thickness, are associated with burden biomarkers and disease severity index scores in Spanish patients with Gaucher’s disease Type I.


2015 ◽  
Vol 48 (4) ◽  
pp. 216-219 ◽  
Author(s):  
Ricardo Andrade Fernandes de Mello ◽  
Melissa Bozzi Nonato Mello ◽  
Laís Bastos Pessanha

Abstract Objective: To evaluate by magnetic resonance imaging changes in bone marrow of patients undergoing treatment for type I Gaucher’s disease. Materials and Methods: Descriptive, cross-sectional study of Gaucher’s disease patients submitted to 3 T magnetic resonance imaging of femurs and lumbar spine. The images were blindly reviewed and the findings were classified according to the semiquantitative bone marrow burden (BMB) scoring system. Results: All of the seven evaluated patients (three men and four women) presented signs of bone marrow infiltration. Osteonecrosis of the femoral head was found in three patients, Erlenmeyer flask deformity in five, and no patient had vertebral body collapse. The mean BMB score was 11, ranging from 9 to 14. Conclusion: Magnetic resonance imaging is currently the method of choice for assessing bone involvement in Gaucher’s disease in adults due to its high sensitivity to detect both focal and diffuse bone marrow changes, and the BMB score is a simplified method for semiquantitative analysis, without depending on advanced sequences or sophisticated hardware, allowing for the classification of the disease extent and assisting in the treatment monitoring.


Sign in / Sign up

Export Citation Format

Share Document